ArticleCellular oncology (Dordrecht, Netherlands)2025

TAK-981 potentiates doxorubicin immunocide in triple-negative breast cancer by IFN I-dependent NK cell stimulation.

Jia Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.